Anti-HIV bnAbs May Provide Long-Lasting Protection Against HIV Infection (image) Scripps Research Institute Share Print E-Mail Caption This computer-generated graphic depicts immune system proteins called broadly neutralizing antibodies (bnAbs; colored) binding to different regions on the HIV envelope protein on the surface of the virus (white). Antibody binding to the envelope protein prevents the virus entering host cells and causing infection. Supported by NIH funding, the Scripps Research-led Consortium for HIV/AIDS Vaccine Development (CHAVD) is developing sequential vaccines designed to elicit anti-HIV bnAbs. Credit Scripps Research Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.